Yunnan Botanee Bio-Technology Group Co Ltd (SHE:300957) — Market Cap & Net Worth
Market Cap & Net Worth: Yunnan Botanee Bio-Technology Group Co Ltd (300957)
Yunnan Botanee Bio-Technology Group Co Ltd (SHE:300957) has a market capitalization of $2.06 Billion (CN¥14.10 Billion) as of June 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #6228 globally and #1309 in its home market, demonstrating a -0.75% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Yunnan Botanee Bio-Technology Group Co Ltd's stock price CN¥33.28 by its total outstanding shares 423600000 (423.60 Million). Review Yunnan Botanee Bio-Technology Group Co L debt and liabilities to assess the company's total debt and financial obligations.
Yunnan Botanee Bio-Technology Group Co Ltd Market Cap History: 2021 to 2026
Yunnan Botanee Bio-Technology Group Co Ltd's market capitalization history from 2021 to 2026. Data shows change from $11.64 Billion to $2.06 Billion (-25.80% CAGR).
Index Memberships
Yunnan Botanee Bio-Technology Group Co Ltd is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ChiNext
CNT
|
$1.43 Trillion | 0.14% | #83 of 100 |
Weight: Yunnan Botanee Bio-Technology Group Co Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Yunnan Botanee Bio-Technology Group Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Yunnan Botanee Bio-Technology Group Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.46x
Yunnan Botanee Bio-Technology Group Co Ltd's market cap is 0.46 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.85x
Yunnan Botanee Bio-Technology Group Co Ltd's market cap is 4.85 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $11.64 Billion | $4.02 Billion | $862.92 Million | 2.89x | 13.49x |
| 2022 | $9.07 Billion | $5.01 Billion | $1.05 Billion | 1.81x | 8.62x |
| 2023 | $4.18 Billion | $5.73 Billion | $756.80 Million | 0.73x | 5.52x |
| 2024 | $2.65 Billion | $5.74 Billion | $503.05 Million | 0.46x | 5.26x |
| 2025 | $2.46 Billion | $5.36 Billion | $505.72 Million | 0.46x | 4.85x |
Competitor Companies of 300957 by Market Capitalization
Companies near Yunnan Botanee Bio-Technology Group Co Ltd in the global market cap rankings as of June 19, 2026.
Key companies related to Yunnan Botanee Bio-Technology Group Co Ltd by market ranking:
- Procter & Gamble Company (NYSE:PG): Ranked #42 globally with a market cap of $351.40 Billion USD.
- LOREAL ADR 1/5/EO 02 (F:LORA): Ranked #98 globally with a market cap of $204.17 Billion USD ( €174.64 Billion EUR).
- LOréal S.A. (PA:OR): Ranked #113 globally with a market cap of $188.75 Billion USD ( €161.45 Billion EUR).
- Unilever PLC (NASDAQ:UNLYD): Ranked #199 globally with a market cap of $120.76 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #42 | Procter & Gamble Company | NYSE:PG | $351.40 Billion | $150.38 |
| #98 | LOREAL ADR 1/5/EO 02 | F:LORA | $204.17 Billion | €72.00 |
| #113 | LOréal S.A. | PA:OR | $188.75 Billion | €387.50 |
| #199 | Unilever PLC | NASDAQ:UNLYD | $120.76 Billion | $55.38 |
Yunnan Botanee Bio-Technology Group Co Ltd Historical Marketcap From 2021 to 2026
Between 2021 and today, Yunnan Botanee Bio-Technology Group Co Ltd's market cap moved from $11.64 Billion to $ 2.06 Billion, with a yearly change of -25.80%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥2.06 Billion | -15.98% |
| 2025 | CN¥2.46 Billion | -7.21% |
| 2024 | CN¥2.65 Billion | -36.65% |
| 2023 | CN¥4.18 Billion | -53.93% |
| 2022 | CN¥9.07 Billion | -22.11% |
| 2021 | CN¥11.64 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Yunnan Botanee Bio-Technology Group Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.06 Billion USD |
| MoneyControl | $2.06 Billion USD |
| MarketWatch | $2.06 Billion USD |
| marketcap.company | $2.06 Billion USD |
| Reuters | $2.06 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Yunnan Botanee Bio-Technology Group Co Ltd
Yunnan Botanee Bio-Technology Group Co.LTD, together with its subsidiaries, engages in the research, development, production, and sale of cosmetics in China and internationally. It operates through Skin Care Products, Medical Instruments, and Makeup segments. The company offers face creams, toners, masks, serums, and lotions; and makeup products, including primers, powders, BB creams, and makeup … Read more